Recommended Topic Related To:


"The U.S. Food and Drug Administration today notified Ranbaxy Laboratories, Ltd., that it is prohibited from manufacturing and distributing active pharmaceutical ingredients (APIs) from its facility in Toansa, India, for FDA-regulated drug product"...



STATICIN® (erythromycin topical solution 1.5%) is indicated for the topical treatment of acne vulgaris.


STATICIN (erythromycin topical solution 1.5%) Solution should be applied over the affected area twice a day after the skin is thoroughly washed with warm water and soap and patted dry. Acne lesions on the face, neck, shoulder, chest, and back may be treated in this manner.

This medication should be applied with applicator top. If fingertips are used, wash hands after application. Drying and peeling may be controlled by reducing the frequency of applications.


STATICIN (erythromycin topical solution 1.5%) SOLUTION, 60 mL plastic bottle with optional appli-cator, NDC 0072-8000-60, NSN-6505-01-118-6098.

Store between 15°C and 25°C (59°F and 77°F).

Westwood-Squibb Pharmaceuticals Inc., Buffalo. N.Y, U.S.A. 14213 A Bristol-Myers Squibb Company. FDA Rev date: 12/15/2002

Last reviewed on RxList: 2/3/2009
This monograph has been modified to include the generic and brand name in many instances.


Report Problems to the Food and Drug Administration


You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

Women's Health

Find out what women really need.